| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |